- Home
- SLGL vs GRNQ Comparison
SLGL vs GRNQ Comparison
Compare SLGL & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- GRNQ
- Stock Information
- Founded
- SLGL 1997
- GRNQ 2013
- Country
- SLGL Israel
- GRNQ Malaysia
- Employees
- SLGL N/A
- GRNQ N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- GRNQ EDP Services
- Sector
- SLGL Health Care
- GRNQ Technology
- Exchange
- SLGL Nasdaq
- GRNQ Nasdaq
- Market Cap
- SLGL 19.3M
- GRNQ 16.4M
- IPO Year
- SLGL 2018
- GRNQ 2018
- Fundamental
- Price
- SLGL $13.00
- GRNQ $1.68
- Analyst Decision
- SLGL Buy
- GRNQ
- Analyst Count
- SLGL 1
- GRNQ 0
- Target Price
- SLGL $40.00
- GRNQ N/A
- AVG Volume (30 Days)
- SLGL 13.9K
- GRNQ 83.1K
- Earning Date
- SLGL 08-15-2025
- GRNQ 08-12-2025
- Dividend Yield
- SLGL N/A
- GRNQ N/A
- EPS Growth
- SLGL N/A
- GRNQ N/A
- EPS
- SLGL N/A
- GRNQ N/A
- Revenue
- SLGL $12,103,000.00
- GRNQ $3,190,761.00
- Revenue This Year
- SLGL N/A
- GRNQ N/A
- Revenue Next Year
- SLGL $31.17
- GRNQ N/A
- P/E Ratio
- SLGL N/A
- GRNQ N/A
- Revenue Growth
- SLGL 603.66
- GRNQ N/A
- 52 Week Low
- SLGL $3.34
- GRNQ $0.80
- 52 Week High
- SLGL $16.50
- GRNQ $2.50
- Technical
- Relative Strength Index (RSI)
- SLGL 87.12
- GRNQ 42.34
- Support Level
- SLGL $10.95
- GRNQ $1.50
- Resistance Level
- SLGL $12.90
- GRNQ $2.24
- Average True Range (ATR)
- SLGL 1.12
- GRNQ 0.19
- MACD
- SLGL 0.40
- GRNQ -0.08
- Stochastic Oscillator
- SLGL 95.73
- GRNQ 20.52
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About GRNQ Greenpro Capital Corp.
Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.